Drug Delivery Devices Market Report and Forecast 2025-2034
Description
The global drug delivery devices market was valued at USD 286.51 Million in 2024, driven by the rising prevalence of chronic conditions and the increasing advancements in drug delivery technologies across the globe. The market is anticipated to grow at a CAGR of 5.80% during the forecast period of 2025-2034, with the values likely to reach USD 503.50 Million by 2034.
Drug Delivery Devices Market Overview
Drug delivery is a method or system used to deliver pharmaceutical compounds to their target site in the body to achieve a therapeutic effect, optimizing drug release, absorption, and bioavailability. The drug delivery systems are focused on technologies that enhance the administration and effectiveness of drugs. Several factors such as the advancement in targeted therapies, the increasing prevalence of chronic diseases, and the rising preference for personalized medicine are anticipated to elevate the market value in the forecast period.
Drug Delivery Devices Market Growth Drivers
Advancements in Drug Delivery Devices to Boost Market Growth
Technological innovations such as the development of PLGA-based drug delivery systems, as highlighted in a study published in March 2024, provide promising advancements in antidiabetic treatments. These biodegradable nanoparticles are increasingly utilized for encapsulating insulin and other antidiabetic agents, providing sustained, controlled release and improved glycemic control. This innovation reduces the need for frequent injections, resulting in a significant improvement in the drug delivery system market.
Drug Delivery Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Personalized Drug Delivery Systems
Personalized medicine is transforming drug delivery, where treatments are tailored to individual genetic profiles, providing more effective and precise drug delivery. Innovations in pharmacogenomics and genetic testing enable personalized therapies, reducing side effects and enhancing patient outcomes.
Growing Need for Non-Invasive Delivery Systems
There is a growing demand for non-invasive drug delivery systems, such as transdermal patches and inhalers, to improve patient safety by eliminating the need for injections. These systems are becoming popular due to their simplicity, pain-free nature, and efficiency in administering drugs.
Wearable and Smart Drug Delivery Devices
Wearable devices such as smart infusion pumps and autoinjectors are becoming increasingly popular for chronic disease management. These devices provide continuous, controlled drug release and real-time monitoring, which enhances patient compliance.
Nanotechnology Advancements
Nanotechnology is transforming drug delivery by enabling the development of nanoparticles and nanocarriers that enhance the stability and bioavailability of drugs. This technology facilitates targeted delivery to specific cells, increasing the effectiveness of treatments, particularly in cancer and chronic disease management.
Drug Delivery Devices Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
Segmentation Based on Product Type to Witness Substantial Growth
Based on the product type, the market is divided into syringes, wearable infusion pumps, autoinjectors and pen injectors, inhalers, transdermal patches, and implantable devices. Syringes are expected to lead the global drug delivery market due to their widespread use in injectable drug delivery. Syringes are indispensable for delivering vaccines, biologics, and medications for chronic conditions, providing accuracy and reliability.
Drug Delivery Devices Market Analysis by Region
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market for drug delivery devices in North America is expected to dominate during the forecast period due to the presence of well-established healthcare infrastructure, high healthcare spending, and the adoption of advanced technologies. The increasing prevalence of chronic diseases and strong regulatory support are key factors that are likely to stimulate market growth in the region.
Leading Players in the Drug Delivery Devices Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc
Medtronic Plc, a leading global medical technology company, designs and manufactures innovative drug delivery solutions. Its SynchroMed™ III implantable infusion system delivers targeted therapy directly into the intrathecal space. The system provides enhanced reliability, security, and efficiency for improved patient outcomes.
Becton, Dickinson and Company (BD)
BD is a leading global medical technology firm revolutionizing healthcare with innovative solutions. In drug delivery, BD specializes in pre-fillable syringe systems, safety devices, and self-injection systems, offering customizable, patient-centric solutions that reduce risks, enhance speed, and improve therapeutic outcomes across diverse drug types and areas.
Pfizer Inc.
Pfizer Inc. is a leading global biopharmaceutical company, innovating treatments for cardiovascular, cancer, pain, and rare diseases. It offers advanced drug delivery systems, including ready-to-use syringes like Carpuject™, Nexject™, and add-vantage™, designed to enhance safety, reduce errors, and improve medication efficiency through innovative, user-friendly solutions and educational learning modules.
Ypsomed Holding AG
Ypsomed is a leading developer of self-medication solutions, specializing in injection and infusion systems. Their Ypsomed delivery systems offer modular platforms for swift clinical and market applications. The YpsoMate 2.25, with an 8 mm needle, ensures ergonomic design, versatility, and enhanced patient comfort, providing various drug formulations effectively.
Other key players in the market include Johnson & Johnson, 3M Company, Novartis AG, F. Hoffmann-La Roche Ltd, AstraZeneca plc, and Bayer AG.
Key Questions Answered in the Drug Delivery Devices Market Report
Drug Delivery Devices Market Overview
Drug delivery is a method or system used to deliver pharmaceutical compounds to their target site in the body to achieve a therapeutic effect, optimizing drug release, absorption, and bioavailability. The drug delivery systems are focused on technologies that enhance the administration and effectiveness of drugs. Several factors such as the advancement in targeted therapies, the increasing prevalence of chronic diseases, and the rising preference for personalized medicine are anticipated to elevate the market value in the forecast period.
Drug Delivery Devices Market Growth Drivers
Advancements in Drug Delivery Devices to Boost Market Growth
Technological innovations such as the development of PLGA-based drug delivery systems, as highlighted in a study published in March 2024, provide promising advancements in antidiabetic treatments. These biodegradable nanoparticles are increasingly utilized for encapsulating insulin and other antidiabetic agents, providing sustained, controlled release and improved glycemic control. This innovation reduces the need for frequent injections, resulting in a significant improvement in the drug delivery system market.
Drug Delivery Devices Market Trends
The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:
Personalized Drug Delivery Systems
Personalized medicine is transforming drug delivery, where treatments are tailored to individual genetic profiles, providing more effective and precise drug delivery. Innovations in pharmacogenomics and genetic testing enable personalized therapies, reducing side effects and enhancing patient outcomes.
Growing Need for Non-Invasive Delivery Systems
There is a growing demand for non-invasive drug delivery systems, such as transdermal patches and inhalers, to improve patient safety by eliminating the need for injections. These systems are becoming popular due to their simplicity, pain-free nature, and efficiency in administering drugs.
Wearable and Smart Drug Delivery Devices
Wearable devices such as smart infusion pumps and autoinjectors are becoming increasingly popular for chronic disease management. These devices provide continuous, controlled drug release and real-time monitoring, which enhances patient compliance.
Nanotechnology Advancements
Nanotechnology is transforming drug delivery by enabling the development of nanoparticles and nanocarriers that enhance the stability and bioavailability of drugs. This technology facilitates targeted delivery to specific cells, increasing the effectiveness of treatments, particularly in cancer and chronic disease management.
Drug Delivery Devices Market Segmentation
The market report offers a detailed analysis of the market based on the following segments:
Market Breakup by Product Type
- Syringes
- Wearable Infusion Pumps
- Autoinjectors and Pen Injectors
- Inhalers
- Transdermal Patches
- Implantable Devices
- Injectable
- Topical
- Inhalation
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Homecare Settings
- Others
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Segmentation Based on Product Type to Witness Substantial Growth
Based on the product type, the market is divided into syringes, wearable infusion pumps, autoinjectors and pen injectors, inhalers, transdermal patches, and implantable devices. Syringes are expected to lead the global drug delivery market due to their widespread use in injectable drug delivery. Syringes are indispensable for delivering vaccines, biologics, and medications for chronic conditions, providing accuracy and reliability.
Drug Delivery Devices Market Analysis by Region
The market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The market for drug delivery devices in North America is expected to dominate during the forecast period due to the presence of well-established healthcare infrastructure, high healthcare spending, and the adoption of advanced technologies. The increasing prevalence of chronic diseases and strong regulatory support are key factors that are likely to stimulate market growth in the region.
Leading Players in the Drug Delivery Devices Market
The key features of the market report comprise patent analysis, grants analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:
Medtronic plc
Medtronic Plc, a leading global medical technology company, designs and manufactures innovative drug delivery solutions. Its SynchroMed™ III implantable infusion system delivers targeted therapy directly into the intrathecal space. The system provides enhanced reliability, security, and efficiency for improved patient outcomes.
Becton, Dickinson and Company (BD)
BD is a leading global medical technology firm revolutionizing healthcare with innovative solutions. In drug delivery, BD specializes in pre-fillable syringe systems, safety devices, and self-injection systems, offering customizable, patient-centric solutions that reduce risks, enhance speed, and improve therapeutic outcomes across diverse drug types and areas.
Pfizer Inc.
Pfizer Inc. is a leading global biopharmaceutical company, innovating treatments for cardiovascular, cancer, pain, and rare diseases. It offers advanced drug delivery systems, including ready-to-use syringes like Carpuject™, Nexject™, and add-vantage™, designed to enhance safety, reduce errors, and improve medication efficiency through innovative, user-friendly solutions and educational learning modules.
Ypsomed Holding AG
Ypsomed is a leading developer of self-medication solutions, specializing in injection and infusion systems. Their Ypsomed delivery systems offer modular platforms for swift clinical and market applications. The YpsoMate 2.25, with an 8 mm needle, ensures ergonomic design, versatility, and enhanced patient comfort, providing various drug formulations effectively.
Other key players in the market include Johnson & Johnson, 3M Company, Novartis AG, F. Hoffmann-La Roche Ltd, AstraZeneca plc, and Bayer AG.
Key Questions Answered in the Drug Delivery Devices Market Report
- What was the drug delivery devices market value in 2024?
- What is the drug delivery devices market forecast outlook for 2025-2034?
- What are the regional markets covered in the EMR report?
- What is the market segmentation based on product type?
- What is the market segmentation based on the delivery route?
- What is the market breakup based on the end user?
- What major factors aid the demand for drug delivery devices?
- How has the market performed so far and how is it anticipated to perform in the coming years?
- What are the major drivers, opportunities, and restraints in the market?
- What are the major trends influencing the market?
- Which regional market is expected to dominate the market share in the forecast period?
- Which country is likely to experience elevated growth during the forecast period?
- Who are the key players involved in the drug delivery devices market?
- What are the current unmet needs and challenges in the market?
- How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?
Table of Contents
400 Pages
- 1 Preface
- 1.1 Objectives of the Study
- 1.2 Key Assumptions
- 1.3 Report Coverage – Key Segmentation and Scope
- 1.4 Research Methodology
- 2 Executive Summary
- 3 Global Drug Delivery Devices Market Overview
- 3.1 Global Drug Delivery Devices Market Historical Value 2018-2024
- 3.2 Global Drug Delivery Devices Market Forecast Value 2025-2034
- 4 Vendor Positioning Analysis
- 4.1 Key Vendors
- 4.2 Prospective Leaders
- 4.3 Niche Leaders
- 4.4 Disruptors
- 5 Global Drug Delivery Devices Market Landscape*
- 5.1 Global Drug Delivery Devices Market: Developers Landscape
- 5.1.1 Analysis by Year of Establishment
- 5.1.2 Analysis by Company Size
- 5.1.3 Analysis by Region
- 5.2 Global Drug Delivery Devices Market: Product Landscape
- 5.2.1 Analysis by Product Type
- 5.2.2 Analysis by Delivery Route
- 6 Global Drug Delivery Devices Market Dynamics
- 6.1 Market Drivers and Constraints
- 6.2 SWOT Analysis
- 6.2.1 Strengths
- 6.2.2 Weaknesses
- 6.2.3 Opportunities
- 6.2.4 Threats
- 6.3 PESTEL Analysis
- 6.3.1 Political
- 6.3.2 Economic
- 6.3.3 Social
- 6.3.4 Technological
- 6.3.5 Legal
- 6.3.6 Environment
- 6.4 Porter’s Five Forces Model
- 6.4.1 Bargaining Power of Suppliers
- 6.4.2 Bargaining Power of Buyers
- 6.4.3 Threat of New Entrants
- 6.4.4 Threat of Substitutes
- 6.4.5 Degree of Rivalry
- 6.5 Key Demand Indicators
- 6.6 Key Price Indicators
- 6.7 Industry Events, Initiatives, and Trends
- 6.8 Value Chain Analysis
- 7 Global Drug Delivery Devices Market Segmentation (218-2034)
- 7.1 Global Drug Delivery Devices Market (2018-2034) by Product Type
- 7.1.1 Market Overview
- 7.1.2 Syringes
- 7.1.3 Wearable Infusion Pumps
- 7.1.4 Autoinjectors and Pen Injectors
- 7.1.5 Inhalers
- 7.1.6 Transdermal Patches
- 7.1.7 Implantable Devices
- 7.2 Global Drug Delivery Devices Market (2018-2034) by Delivery Route
- 7.2.1 Market Overview
- 7.2.2 Injectable
- 7.2.3 Topical
- 7.2.4 Inhalation
- 7.3 Global Drug Delivery Devices Market (2018-2034) by End User
- 7.3.1 Market Overview
- 7.3.2 Hospitals and Clinics
- 7.3.3 Ambulatory Surgical Centers
- 7.3.4 Homecare Settings
- 7.3.5 Others
- 7.4 Global Drug Delivery Devices Market (2018-2034) by Region
- 7.4.1 Market Overview
- 7.4.2 North America
- 7.4.3 Europe
- 7.4.4 Asia Pacific
- 7.4.5 Latin America
- 7.4.6 Middle East and Africa
- 8 North America Drug Delivery Devices Market (218-2034)
- 8.1 North America Drug Delivery Devices Market (2018-2034) by Product Type
- 8.1.1 Market Overview
- 8.1.2 Syringes
- 8.1.3 Wearable Infusion Pumps
- 8.1.4 Autoinjectors and Pen Injectors
- 8.1.5 Inhalers
- 8.1.6 Transdermal Patches
- 8.1.7 Implantable Devices
- 8.2 North America Drug Delivery Devices Market (2018-2034) by Delivery Route
- 8.2.1 Market Overview
- 8.2.2 Injectable
- 8.2.3 Topical
- 8.2.4 Inhalation
- 8.3 North America Drug Delivery Devices Market (2018-2034) by End User
- 8.3.1 Market Overview
- 8.3.2 Hospitals and Clinics
- 8.3.3 Ambulatory Surgical Centers
- 8.3.4 Homecare Settings
- 8.3.5 Others
- 8.4 North America Drug Delivery Devices Market (2018-2034) by Country
- 8.4.1 United States of America
- 8.4.2 Canada
- 9 Europe Drug Delivery Devices Market (218-2034)
- 9.1 Europe Drug Delivery Devices Market (2018-2034) by Product Type
- 9.1.1 Market Overview
- 9.1.2 Syringes
- 9.1.3 Wearable Infusion Pumps
- 9.1.4 Autoinjectors and Pen Injectors
- 9.1.5 Inhalers
- 9.1.6 Transdermal Patches
- 9.1.7 Implantable Devices
- 9.2 Europe Drug Delivery Devices Market (2018-2034) by Delivery Route
- 9.2.1 Market Overview
- 9.2.2 Injectable
- 9.2.3 Topical
- 9.2.4 Inhalation
- 9.3 Europe Drug Delivery Devices Market (2018-2034) by End User
- 9.3.1 Market Overview
- 9.3.2 Hospitals and Clinics
- 9.3.3 Ambulatory Surgical Centers
- 9.3.4 Homecare Settings
- 9.3.5 Others
- 9.4 Europe Drug Delivery Devices Market (2018-2034) by Country
- 9.4.1 United Kingdom
- 9.4.2 Germany
- 9.4.3 France
- 9.4.4 Italy
- 9.4.5 Others
- 10 Asia Pacific Drug Delivery Devices Market (218-2034)
- 10.1 Asia Pacific Drug Delivery Devices Market (2018-2034) by Product Type
- 10.1.1 Market Overview
- 10.1.2 Syringes
- 10.1.3 Wearable Infusion Pumps
- 10.1.4 Autoinjectors and Pen Injectors
- 10.1.5 Inhalers
- 10.1.6 Transdermal Patches
- 10.1.7 Implantable Devices
- 10.2 Asia Pacific Drug Delivery Devices Market (2018-2034) by Delivery Route
- 10.2.1 Market Overview
- 10.2.2 Injectable
- 10.2.3 Topical
- 10.2.4 Inhalation
- 10.3 Asia Pacific Drug Delivery Devices Market (2018-2034) by End User
- 10.3.1 Market Overview
- 10.3.2 Hospitals and Clinics
- 10.3.3 Ambulatory Surgical Centers
- 10.3.4 Homecare Settings
- 10.3.5 Others
- 10.4 Asia Pacific Drug Delivery Devices Market (2018-2034) by Country
- 10.4.1 China
- 10.4.2 Japan
- 10.4.3 India
- 10.4.4 ASEAN
- 10.4.5 Australia
- 10.4.6 Others
- 11 Latin America Drug Delivery Devices Market (218-2034)
- 11.1 Latin America Drug Delivery Devices Market (2018-2034) by Product Type
- 11.1.1 Market Overview
- 11.1.2 Syringes
- 11.1.3 Wearable Infusion Pumps
- 11.1.4 Autoinjectors and Pen Injectors
- 11.1.5 Inhalers
- 11.1.6 Transdermal Patches
- 11.1.7 Implantable Devices
- 11.2 Latin America Drug Delivery Devices Market (2018-2034) by Delivery Route
- 11.2.1 Market Overview
- 11.2.2 Injectable
- 11.2.3 Topical
- 11.2.4 Inhalation
- 11.3 Latin America Drug Delivery Devices Market (2018-2034) by End User
- 11.3.1 Market Overview
- 11.3.2 Hospitals and Clinics
- 11.3.3 Ambulatory Surgical Centers
- 11.3.4 Homecare Settings
- 11.3.5 Others
- 11.4 Latin America Drug Delivery Devices Market (2018-2034) by Country
- 11.4.1 Brazil
- 11.4.2 Argentina
- 11.4.3 Mexico
- 11.4.4 Others
- 12 Middle East and Africa Drug Delivery Devices Market (218-2034)
- 12.1 Middle East and Africa Drug Delivery Devices Market (2018-2034) by Product Type
- 12.1.1 Market Overview
- 12.1.2 Syringes
- 12.1.3 Wearable Infusion Pumps
- 12.1.4 Autoinjectors and Pen Injectors
- 12.1.5 Inhalers
- 12.1.6 Transdermal Patches
- 12.1.7 Implantable Devices
- 12.2 Middle East and Africa Drug Delivery Devices Market (2018-2034) by Delivery Route
- 12.2.1 Market Overview
- 12.2.2 Injectable
- 12.2.3 Topical
- 12.2.4 Inhalation
- 12.3 Middle East and Africa Drug Delivery Devices Market (2018-2034) by End User
- 12.3.1 Market Overview
- 12.3.2 Hospitals and Clinics
- 12.3.3 Ambulatory Surgical Centers
- 12.3.4 Homecare Settings
- 12.3.5 Others
- 12.4 Middle East and Africa Drug Delivery Devices Market (2018-2034) by Country
- 12.4.1 Saudi Arabia
- 12.4.2 United Arab Emirates
- 12.4.3 Nigeria
- 12.4.4 South Africa
- 12.4.5 Others
- 13 Patent Analysis
- 13.1 Analysis by Type of Patent
- 13.2 Analysis by Publication Year
- 13.3 Analysis by Issuing Authority
- 13.4 Analysis by Patent Age
- 13.5 Analysis by CPC Analysis
- 13.6 Analysis by Patent Valuation
- 14 Grants Analysis
- 14.1 Analysis by Year
- 14.2 Analysis by Amount Awarded
- 14.3 Analysis by Issuing Authority
- 14.4 Analysis by Grant Delivery Route
- 14.5 Analysis by Funding Institute
- 14.6 Analysis by NIH Departments
- 14.7 Analysis by Recipient Organization
- 15 Funding and Investment Analysis
- 15.1 Analysis by Funding Instances
- 15.2 Analysis by Drug Class of Funding
- 15.3 Analysis by Funding Amount
- 15.4 Analysis by Leading Players
- 15.5 Analysis by Leading Investors
- 15.6 Analysis by Geography
- 16 Strategic Initiatives
- 16.1 Analysis by Partnership Instances
- 16.2 Analysis by Drug Class of Partnership
- 16.3 Analysis by Leading Players
- 16.4 Analysis by Geography
- 17 Supplier Landscape
- 17.1 Market Share Analysis, By Region (Top 5 Companies)
- 17.1.1 Market Share Analysis: Global
- 17.1.2 Market Share Analysis: North America
- 17.1.3 Market Share Analysis: Europe
- 17.1.4 Market Share Analysis: Asia Pacific
- 17.1.5 Market Share Analysis: Others
- 17.2 Johnson & Johnson
- 17.2.1 Financial Analysis
- 17.2.2 Product Portfolio
- 17.2.3 Demographic Reach and Achievements
- 17.2.4 Company News and Development
- 17.2.5 Certifications
- 17.3 Medtronic plc
- 17.3.1 Financial Analysis
- 17.3.2 Product Portfolio
- 17.3.3 Demographic Reach and Achievements
- 17.3.4 Company News and Development
- 17.3.5 Certifications
- 17.4 Becton, Dickinson and Company (BD)
- 17.4.1 Financial Analysis
- 17.4.2 Product Portfolio
- 17.4.3 Demographic Reach and Achievements
- 17.4.4 Company News and Development
- 17.4.5 Certifications
- 17.5 3M Company
- 17.5.1 Financial Analysis
- 17.5.2 Product Portfolio
- 17.5.3 Demographic Reach and Achievements
- 17.5.4 Company News and Development
- 17.5.5 Certifications
- 17.6 Novartis AG
- 17.6.1 Financial Analysis
- 17.6.2 Product Portfolio
- 17.6.3 Demographic Reach and Achievements
- 17.6.4 Company News and Development
- 17.6.5 Certifications
- 17.7 Pfizer Inc.
- 17.7.1 Financial Analysis
- 17.7.2 Product Portfolio
- 17.7.3 Demographic Reach and Achievements
- 17.7.4 Company News and Development
- 17.7.5 Certifications
- 17.8 F. Hoffmann-La Roche Ltd
- 17.8.1 Financial Analysis
- 17.8.2 Product Portfolio
- 17.8.3 Demographic Reach and Achievements
- 17.8.4 Company News and Development
- 17.8.5 Certifications
- 17.9 AstraZeneca plc
- 17.9.1 Financial Analysis
- 17.9.2 Product Portfolio
- 17.9.3 Demographic Reach and Achievements
- 17.9.4 Company News and Development
- 17.9.5 Certifications
- 17.10 Ypsomed Holding AG
- 17.10.1 Financial Analysis
- 17.10.2 Product Portfolio
- 17.10.3 Demographic Reach and Achievements
- 17.10.4 Company News and Development
- 17.10.5 Certifications
- 17.11 Bayer AG
- 17.11.1 Financial Analysis
- 17.11.2 Product Portfolio
- 17.11.3 Demographic Reach and Achievements
- 17.11.4 Company News and Development
- 17.11.5 Certifications
- 18 Global Drug Delivery Devices Market – Distribution Model (Additional Insight)
- 18.1 Overview
- 18.2 Potential Distributors
- 18.3 Key Parameters for Distribution Partner Assessment
- 19 Key Opinion Leaders (KOL) Insights (Additional Insight)
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
